Standout Papers

Vigorous HIV-1-Specific CD4 <sup>+</sup> T Cell Responses Associated with Control of Viremia... 1997 2026 2006 2016 1.5k
  1. Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia (1997)
    Eric Rosenberg, James M. Billingsley et al. Science
  2. Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy (2001)
    Colleen Hadigan, Colleen Corcoran et al. Clinical Infectious Diseases
  3. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults (2016)
    Huldrych F. Günthard, Michael S. Saag et al. JAMA
  4. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors (2020)
    Eric A. Meyerowitz, Aaron Richterman et al. Annals of Internal Medicine
  5. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials (2019)
    Paul E. Sax, Kristine M. Erlandson et al. Clinical Infectious Diseases
  6. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults (2018)
    Michael S. Saag, Constance A. Benson et al. JAMA
  7. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 (2011)
    Grace A. McComsey, Douglas Kitch et al. The Journal of Infectious Diseases
  8. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults (2022)
    Rajesh T. Gandhi, Roger Bedimo et al. JAMA
  9. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial (2017)
    Paul E. Sax, Anton Pozniak et al. The Lancet

Immediate Impact

8 by Nobel laureates 12 from Science/Nature 79 standout
Sub-graph 1 of 15

Citing Papers

Diagnosis and Management of Cirrhosis and Its Complications
2023 Standout
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
1 intermediate paper

Works of Paul E. Sax being referenced

Brief Report
2016
Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
Paul E. Sax 9375 6852 4526 240 13.8k
José M. Gatell 11265 8671 3668 217 14.5k
Joel E. Gallant 11580 9536 3346 149 15.4k
Matthias Cavassini 7587 4887 2959 364 11.5k
Eric S. Daar 7180 7119 2500 236 11.3k
Joep M. A. Lange 9135 9247 1990 293 14.0k
Scott M. Hammer 12124 10061 2241 129 15.7k
Stefano Vella 10242 8061 2197 247 13.3k
Dominique Costagliola 8803 7253 3859 444 17.4k
Bruno Ledergerber 10958 7563 4891 220 15.9k
Geneviève Chêne 7525 5187 3172 419 15.5k

All Works

Loading papers...

Rankless by CCL
2026